PROSTHETICS ישראל - עברית - Ministry of Health

prosthetics

אלפא ביו טכ. בע"מ - רופא שיניים - the alpha-bio instruments system is indicated for use in surgical and restorative applications for placement in the bone of the upper or lower jaw to provide support for prosthetic devices, such as artificial teeth, in order to restore the patient's chewing function.

אוקספה ישראל - עברית - Ministry of Health

אוקספה

abbott medical laboratories ltd - acid casein 5.9 g / 100 ml; artificial vanilla 116 mg / 100 ml - liquid - combinations of electrolytes - oxepa is clinically shown to modulate the inflammatory response in critically ill, mechanically ventilated patients. it is appropriate for patients who have sepsis, ali (acute lung injury), or ards (acute respiratory distress syndrome).

וי-קרימה ישראל - עברית - Ministry of Health

וי-קרימה

vitamed pharmaceutical industries ltd - hydroxyethylcellulose; povidone - תמיסה - povidone 1.65 %; hydroxyethylcellulose 0.4 % - other ophthalmologicals - artificial tears.

זימקס ישראל - עברית - Ministry of Health

זימקס

pfizer pharmaceuticals israel ltd - azithromycin - אבקה להכנת תרחיף - azithromycin 2.096 g - azithromycin - azithromycin - zmax is indicated for the treatment of patients 18 years of age and above with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. adults: acute bacterial sinusitis due to haemophilus influenzae moraxella catarrhalis or streptococcus pneumoniae. community-acquired pneumonia due to chlamydophila pneumoniae, haemophilus influenzae mycoplasma pneumoniae or streptococcus pneumoniae in patients appropriate for oral therapy.

אפיביר 150 מג ישראל - עברית - Ministry of Health

אפיביר 150 מג

glaxo smith kline (israel) ltd - lamivudine - טבליות מצופות פילם - lamivudine 150 mg - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.

זפיקס תמיסה לשתייה ישראל - עברית - Ministry of Health

זפיקס תמיסה לשתייה

glaxo smith kline (israel) ltd - lamivudine - תמיסה (פומי) - lamivudine 5 mg/ml - lamivudine - lamivudine - zeffix is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.

אפיביר תמיסה לשתיה ישראל - עברית - Ministry of Health

אפיביר תמיסה לשתיה

glaxo smith kline (israel) ltd - lamivudine - תמיסה (פומי) - lamivudine 10 mg/ml - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.

אפיביר 300 מג ישראל - עברית - Ministry of Health

אפיביר 300 מג

glaxo smith kline (israel) ltd - lamivudine - טבליות מצופות פילם - lamivudine 300 mg - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.

אקטיק 400 מקג ישראל - עברית - Ministry of Health

אקטיק 400 מקג

abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 400 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

אקטיק 800 מקג ישראל - עברית - Ministry of Health

אקטיק 800 מקג

abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 800 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.